Literature DB >> 20562239

Reduced VLDL clearance in Apoe(-/-)Npc1(-/-) mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels.

Minako Ishibashi1, David Masson, Marit Westerterp, Nan Wang, Scott Sayers, Rong Li, Carrie L Welch, Alan R Tall.   

Abstract

Niemann-Pick type C1 (NPC1) promotes the transport of LDL receptor (LDL-R)-derived cholesterol from late endosomes/lysosomes to other cellular compartments. NPC1-deficient cells showed impaired regulation of liver_X receptor (LXR) and sterol regulatory element-binding protein (SREBP) target genes. We observed that Apoe(-/-)Npc1(-/-) mice displayed a marked increase in total plasma cholesterol mainly due to increased VLDL, reflecting decreased clearance. Although nuclear SREBP-2 and Ldlr mRNA levels were increased in Apoe(-/-)Npc1(-/-) liver, LDL-R protein levels were decreased in association with marked induction of proprotein convertase subtilisin/kexin type 9 (Pcsk9) and inducible degrader of the LDL-R (Idol), both known to promote proteolytic degradation of LDL-R. While Pcsk9 is known to be an SREBP-2 target, marked upregulation of IDOL in Apoe(-/-)Npc1(-/-) liver was unexpected. However, several other LXR target genes also increased in Apoe(-/-)Npc1(-/-) liver, suggesting increased synthesis of endogenous LXR ligands secondary to activation of sterol biosynthesis. In conclusion, we demonstrate that NPC1 deficiency has a major impact on VLDL metabolism in Apoe(-/-) mice through modulation of hepatic LDL-R protein levels. In contrast to modest induction of hepatic IDOL with synthetic LXR ligands, a striking upregulation of IDOL in Apoe(-/-)Npc1(-/-) mice could indicate a role of endogenous LXR ligands in regulation of hepatic IDOL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20562239      PMCID: PMC2918447          DOI: 10.1194/jlr.M006163

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  37 in total

1.  Liver disease with altered bile acid transport in Niemann-Pick C mice on a high-fat, 1% cholesterol diet.

Authors:  Robert P Erickson; Achyut Bhattacharyya; Robert J Hunter; Randall A Heidenreich; Nathan J Cherrington
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-03-24       Impact factor: 4.052

2.  Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis.

Authors:  E D Carstea; J A Morris; K G Coleman; S K Loftus; D Zhang; C Cummings; J Gu; M A Rosenfeld; W J Pavan; D B Krizman; J Nagle; M H Polymeropoulos; S L Sturley; Y A Ioannou; M E Higgins; M Comly; A Cooney; A Brown; C R Kaneski; E J Blanchette-Mackie; N K Dwyer; E B Neufeld; T Y Chang; L Liscum; J F Strauss; K Ohno; M Zeigler; R Carmi; J Sokol; D Markie; R R O'Neill; O P van Diggelen; M Elleder; M C Patterson; R O Brady; M T Vanier; P G Pentchev; D A Tagle
Journal:  Science       Date:  1997-07-11       Impact factor: 47.728

3.  Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands.

Authors:  Chendong Yang; Jeffrey G McDonald; Amit Patel; Yuan Zhang; Michihisa Umetani; Fang Xu; Emily J Westover; Douglas F Covey; David J Mangelsdorf; Jonathan C Cohen; Helen H Hobbs
Journal:  J Biol Chem       Date:  2006-07-20       Impact factor: 5.157

4.  Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment.

Authors:  Kara N Maxwell; Edward A Fisher; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-27       Impact factor: 11.205

5.  Cholesterol accumulation in tissues of the Niemann-pick type C mouse is determined by the rate of lipoprotein-cholesterol uptake through the coated-pit pathway in each organ.

Authors:  C Xie; S D Turley; J M Dietschy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

6.  Lipoprotein lipase expression exclusively in liver. A mouse model for metabolism in the neonatal period and during cachexia.

Authors:  M Merkel; P H Weinstock; T Chajek-Shaul; H Radner; B Yin; J L Breslow; I J Goldberg
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

7.  Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE-deficient mice.

Authors:  M J Amar; K A Dugi; C C Haudenschild; R D Shamburek; B Foger; M Chase; A Bensadoun; R F Hoyt; H B Brewer; S Santamarina-Fojo
Journal:  J Lipid Res       Date:  1998-12       Impact factor: 5.922

8.  Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo.

Authors:  M Merkel; Y Kako; H Radner; I S Cho; R Ramasamy; J D Brunzell; I J Goldberg; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

9.  The steroidal analog GW707 activates the SREBP pathway through disruption of intracellular cholesterol trafficking.

Authors:  Jessie Zhang; Nicole Dudley-Rucker; Jan R Crowley; Elvira Lopez-Perez; Marc Issandou; Jean E Schaffer; Daniel S Ory
Journal:  J Lipid Res       Date:  2003-11-16       Impact factor: 5.922

10.  Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c.

Authors:  Philippe Costet; Bertrand Cariou; Gilles Lambert; Florent Lalanne; Bernard Lardeux; Anne-Laure Jarnoux; Aldo Grefhorst; Bart Staels; Michel Krempf
Journal:  J Biol Chem       Date:  2006-01-06       Impact factor: 5.157

View more
  5 in total

1.  Stable liver-specific expression of human IDOL in humanized mice raises plasma cholesterol.

Authors:  Salam Ibrahim; Suryanarayan Somanathan; Jeffrey Billheimer; James M Wilson; Daniel J Rader
Journal:  Cardiovasc Res       Date:  2016-01-19       Impact factor: 10.787

2.  IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.

Authors:  Elena Scotti; Martino Calamai; Chris N Goulbourne; Li Zhang; Cynthia Hong; Ron R Lin; Jinkuk Choi; Paul F Pilch; Loren G Fong; Peng Zou; Alice Y Ting; Francesco S Pavone; Stephen G Young; Peter Tontonoz
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

3.  ABCC6- a new player in cellular cholesterol and lipoprotein metabolism?

Authors:  Patricia Kuzaj; Joachim Kuhn; Mareike Dabisch-Ruthe; Isabel Faust; Christian Götting; Cornelius Knabbe; Doris Hendig
Journal:  Lipids Health Dis       Date:  2014-07-27       Impact factor: 3.876

Review 4.  Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9).

Authors:  Rainer Schulz; Klaus-Dieter Schlüter; Ulrich Laufs
Journal:  Basic Res Cardiol       Date:  2015-01-20       Impact factor: 17.165

5.  Perturbed rhythmic activation of signaling pathways in mice deficient for Sterol Carrier Protein 2-dependent diurnal lipid transport and metabolism.

Authors:  Céline Jouffe; Cédric Gobet; Eva Martin; Sylviane Métairon; Delphine Morin-Rivron; Mojgan Masoodi; Frédéric Gachon
Journal:  Sci Rep       Date:  2016-04-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.